Moderna booster vaccine produces “reassuring” antibody resistance to Omicron

American pharmaceutical giant Moderna (Nasdaq: MRNA) has released new data on the efficacy of a booster shot to produce an immune response against the highly-transmissive Omicron variant of COVID-19, noting the results are “reassuring”.

The company says that the currently authorised 50…